| Name | Title | Contact Details |
|---|
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
From strategy to execution. We help our clients to be visionary in their ambition, and pragmatic in their realization Many strategies fail due to a lack of effective execution. At Strategy&, we work with our clients to solve their toughest problems by coming up with a strategy that is executable – defined by clear choices and a strong vision for the future. We have the required expertise and work hand-in-hand with our colleagues from the PwC network. The result: reliable strategy consulting – from initial analysis to measurable results and sustainable outcomes. Driven by a spirit of innovation and guided by pragmatism, a professional attitude, empathy, and a strong sense of responsibility. This is how we make strategy real at Strategy&.
Small business banking and money management tools to put you in complete control of what your business is earning, spending and saving. The official banking platform of Profit First. Bank with Relay for: ✅ No fees or minimum balances that tie up cash flow ✅ Up to 20 checking accounts to organize income and expenses ✅ Spending management using 50 physical or virtual debit cards ✅ Payments and deposits via ACH transfers, checks and wires ✅ Secure, role-based access to team members and financial advisors ✅ Personalized customer support by email, phone or chat - Relay is a financial technology company, not a bank. Banking services and FDIC insurance are provided through Thread Bank; Member FDIC. The Relay Visa® Debit Card is issued by Thread Bank pursuant to a license from Visa U.S.A. Inc. and may be used everywhere Visa® debit cards are accepted.
BASF is a global chemical company founded in 1865 in Mannheim, Germany. Initially focused on dyes and inorganic chemicals, it has grown to become the worlds leading chemical enterprise, operating across six continents. The company emphasizes innovation, sustainability, and customer-centric solutions. BASFs diverse portfolio includes chemicals, materials, industrial solutions, surface technologies, nutrition, and agricultural solutions. It offers products such as synthetic dyes, fertilizers, polymers, crop protection products, and ingredients for the food and personal care industries. With a strong presence in various sectors like automotive, construction, and agriculture, BASF serves a wide range of customers globally. The company is committed to corporate responsibility, integrating environmental and social considerations into its operations. Its research and development efforts focus on resource efficiency, renewable energy, and principles of the circular economy. BASFs rebranding in 2015 reflects its dedication to creating sustainable solutions.